Exosome RNA Exosome RNA Research & Industry News
Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today that it has been awarded a contract with National Institute of Allergy and Infectious...
Read More »Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles
